Position in RDNT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$30,486,541
-$6,460,058 QoQ
Shares Held
545,474
+5.3% QoQ
Ownership
0.694%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Penserra Capital Management LLC holds $32,206,536 across 12 Diagnostics & Research names. RDNT ranks #1 (94.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDNT |
RadNet, Inc.
This page
|
545,474 | $30,486,541 | |
| 2 | DGX |
Quest Diagnostics Inc
|
6,261 | $1,227,029 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
963 | $164,229 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
116 | $146,298 | |
| 5 | NTRA |
Natera, Inc.
|
727 | $145,392 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
30 | $14,745 | |
| 7 | DHR |
Danaher Corp /De/
|
57 | $10,807 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
6 | $3,371 |
All Filings in RDNT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,486,541 | 545,474 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $36,946,599 | 517,822 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $36,510,458 | 479,077 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $19,018,183 | 334,180 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $10,088,237 | 202,901 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $10,048,788 | 143,883 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,697,286 | 67,694 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,035,371 | 68,489 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||